Search
Search Results
##search.searchResults.foundPlural##
-
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
3729PDF: 3061HTML: 182 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3558PDF: 1367HTML: 167 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
3989PDF: 1533HTML: 828 -
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
2442PDF: 841HTML: 2109 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3423PDF: 2331HTML: 1410 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
1976PDF: 1593HTML: 344 -
-
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
3971PDF: 1113HTML: 1914Fig.1: 204Fig. 2: 101Table 1: 183Table2: 198Table 3: 180 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3383PDF: 1453HTML: 64 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4647PDF: 1507HTML: 2229Untitled: 187Untitled: 202Untitled: 209Untitled: 193Untitled: 193 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1332PDF: 794HTML: 3103 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3100PDF: 1374HTML: 5831Fig1-Ag-Pil: 192Ag-Pil Fig.2: 196 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1200PDF: 450HTML: 18540Figure 1: 151Figure 2: 137Figure 3: 153Figure 4: 185Figure 5: 156 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1221HTML: 281PDF: 894Suppl. Files: 431 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1166PDF: 448HTML: 129 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2513PDF: 1568HTML: 2333Table1: 172 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
1957PDF: 763HTML: 1025 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3134PDF: 973HTML: 1986 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1582PDF: 699HTML: 452 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
2972PDF: 833HTML: 7148Kost Fig1: 163Kost Fig 2: 154Kost Fig3: 149Kost Fig 4: 166Kost Fig5: 162Kost fig 6: 149 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2203PDF: 1290HTML: 17055Bassan Fig.1: 133Bassan Fig.2: 129Bassan Fig.4: 126Fig.3: 162 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1421PDF: 894HTML: 208 -
NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION
1687PDF: 956HTML: 1766Tables: 162 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1060PDF: 457HTML: 211 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1226PDF: 587HTML: 3051 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
3950PDF: 1893HTML: 5190Table 1: 165 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3119PDF: 745HTML: 2912Figure 1a and 1b: 133Figure 2: 136Figure 3: 158Figure 4: 142Figure 5: 144Tables 1-5: 140 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4237PDF: 1447HTML: 1531Untitled: 209 -
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1463PDF: 726HTML: 2105Untitled: 175Untitled: 170Untitled: 179Untitled: 162Untitled: 178 -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4302PDF: 1574HTML: 3384Tables and Images: 194 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1478PDF: 560HTML: 170 -
The labyrinth of pyrexia of unknown origin: A case of intravascular B cell lymphoma
1708PDF: 655HTML: 2391Untitled: 131Figure 1 a: 140Figure 1 b: 147Fig 1 c: 126Figure 1 d: 173 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1435PDF: 350HTML: 181 -







